Drug profile · INN
tripelennamine citrate
PBZ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tripelennamine citrate (PBZ) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN tripelennamine citrate
Brand PBZ
Route ORAL
Formulation ELIXIR
Frequently asked questions
What is tripelennamine citrate?
tripelennamine citrate (PBZ) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tripelennamine citrate?
PBZ is a marketed brand name for tripelennamine citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tripelennamine citrate?
tripelennamine citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.